| Literature DB >> 26884492 |
Osamu Kunii1, Mohammed A Yassin1, Eliud Wandwalo2.
Abstract
The Global Fund to fight AIDS, Tuberculosis and Malaria provides over three-quarters of all international financing towards TB programs with US$4.7 billion disbursed, supporting provision of treatment for 13.2 million patients with smear-positive TB and 210 000 patients with multidrug-resistant TB in over 100 countries since 2002. In 2013, the Global Fund launched a new funding model that, among others, is advancing strategic investments to maximize impact, addressing 'missing' TB cases, enhancing a synergistic response to TB/HIV dual epidemics, and building resilient and sustainable systems for health. A new Global Fund Strategy is under development through consultation with various stakeholders, with which the Global Fund will work to play a more catalytic role and foster innovations to end the TB epidemic.Entities:
Keywords: End epidemic; Innovation; Partnership; Strategic investment for impact; The Global Fund
Mesh：
Year: 2016 PMID： 26884492 DOI： 10.1093/trstmh/trw005
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN： 0035-9203 Impact factor: 2.184